RxDoctor Payments DataLook up a doctor →

Courtney Auman, MD

Pain Medicine · Jacksonville, NCNPI 1154563591

Payments from drug & device makers

$210,453in general payments, 2019–2025

Across 1,018 payments — averaging $206.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$168K
  • Saluda Medical Americas, Inc.$29K
  • AbbVie$7K
  • Nevro Corp.$631
  • Spinal Simplicity, LLC$467
  • Vertos Medical, Inc.$459
  • plus $5K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific498$168,225
Saluda Medical Americas, Inc.58$28,525
AbbVie(2 entities)126$6,695
Nevro Corp.12$631
Spinal Simplicity, LLC6$467
Vertos Medical, Inc.18$459
Collegium Pharmaceutical, Inc.23$374
Merz Pharmaceuticals, LLC14$338
Pfizer19$287
Amgen(2 entities)14$255
Scilex Pharmaceuticals Inc.10$253
Abbott15$235
Supernus Pharmaceuticals, Inc.24$228
Arbor Pharmaceuticals, Inc.15$213
Forte Bio-pharma LLC7$202
Painteq LLC3$178
Virtus Pharmaceuticals LLC8$170
Lilly USA, LLC11$169
Si-bone, Inc.3$168
Teva Pharmaceuticals USA, Inc.9$144
Lundbeck LLC6$137
Biodelivery Sciences International, Inc.10$130
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$126
Novartis8$123
Globus Medical4$106
Biohaven Pharmaceuticals, Inc.6$94
Impel Pharmaceuticals Inc.5$91
Vertex4$91
Sentynl Therapeutics, Inc.6$88
GRT US Holding, Inc.3$88
MDD US Operations, LLC5$86
Idorsia Pharmaceuticals US Inc5$83
Redhill Biopharma Inc.4$78
Azurity Pharmaceuticals, Inc.4$75
Biohaven Pharmaceutical Holding Company Ltd.5$75
Medtronic3$74
Almatica Pharma LLC3$69
Novo Nordisk4$66
AstraZeneca5$60
Zyla Life Sciences, Inc.4$54
Biotronik NRO, Inc.2$52
Valinor Pharma, LLC2$47
MML US, Inc.1$42
Upsher-smith Laboratories LLC2$35
Kaleo, Inc.2$33
Amneal Pharmaceuticals LLC2$33
Protega Pharmaceutials Inc2$32
Fidia Pharma USA Inc.1$23
Baudax Bio Inc.1$22
Averitas Pharma Inc.1$21
Nalu Medical, Inc.1$18
Daiichi Sankyo Inc.1$15
Promius Pharma LLC1$14
International Rehabilitative Sciences, Inc1$14
Curonix LLC1$14
IBSA Pharma Inc.1$12
Stimwave Technologies Incorporated1$11

How this compares

$210,453 in reported general payments places this provider in the 95th percentile of 182 pain medicine providers in North Carolina.

See all pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$531,321
Medicare patients
348
Services billed
39,614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Jacksonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →